Is a complete LON/0JAV research report available?

No complete published report is available for lon/0JAV (LON/0JAV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0JAV (LON/0JAV)

London Stock Exchange: LON/0JAV · USD

$127

+2.32 (+1.9%)· Recorded snapshot

Market cap	20.5B
Revenue (ttm)	857.4M
Net income (ttm)	-659.7M
EPS (ttm)	-$3.08
Volume	573
Beta	0.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 857.4M
Net income (ttm): -659.7M
EPS (ttm): -$3.08
Market cap: 20.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-04 02:00 UTC

All LON/0JAV indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	1,664
Employees Change	359%
Employees Change Percent	39.36
Enterprise value	$20.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US4576693075
Last refreshed	2026-09-04
Market cap	$20.5B
Price	$127
Price currency	USD
Rev Per Employee	515,285.76x
Sector	Healthcare
Sector PE	21.67
Sector PE Fwd	13.82
Sic	2836
Symbol	lon/0JAV
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.22%
EV/Sales	23.94x
FCF yield	-2.97%
P/B ratio	35.86x
P/S ratio	23.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-71.43%
EBITDA Margin	-69.88%
Gross margin	83.46%
Gross Profit	$715.6M
Gross Profit Growth	214.97%
Gross Profit Growth Q	351.57%
Gross Profit Growth3 Y	64.7%
Gross Profit Growth5 Y	49.19%
Net Income	$-659.7M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-76.4%
Profit Margin	-76.94%
Profit Per Employee	$-396,467
ROA	-22.17
Roa5y	-25.98
ROCE	-48.84
ROE	-87.22
ROIC	-29.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.93%
Cagr3y	80.56%
Cagr5y	35.56%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	185.76x
Revenue Growth Q	296.11x
Revenue Growth Qo Q	39.06x
Revenue Growth Quarters	22x
Revenue Growth Years	7x
Revenue Growth3 Y	61.62x
Revenue Growth5 Y	46.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.5
Assets	$1.6B
Cash	$874.5M
Current Assets	$1.2B
Current Liabilities	$325.1M
Debt	$557.5M
Debt Equity	$0.98
Debt FCF	$-0.92
Equity	$570.9M
Interest Coverage	-9.99
Liabilities	$1B
Long Term Assets	$373.9M
Long Term Liabilities	$688.6M
Net Cash	$317M
Net Cash By Market Cap	$1.55
Net Cash Growth	-62.37%
Net Debt Equity	$-0.56
Tangible Book Value	$413.4M
Tangible Book Value Per Share	$1.89
WACC	8.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.72
Inventory Turnover	1.51
Net Working Capital	$33.7M
Quick ratio	3.14
Working Capital	$900.8M
Working Capital Turnover	$0.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.92%
200-day SMA	141.5
3Y total return	488.92%
50-day SMA	115.3
50-day SMA vs 200-day SMA	50under200
5Y total return	357.61%
All Time High	214
All Time High Change	-40.87%
All Time High Date	2025-12-02
All Time Low	16.59
All Time Low Change	662.92%
All Time Low Date	2023-03-27
ATR	5.23
Beta	0.79
Ch YTD	-27.37
High	127
High52	214
High52 Date	2025-12-02
High52ch	-40.87%
Low	124.1
Low52	91.59
Low52 Date	2026-06-11
Low52ch	38.15%
Ma50ch	9.76%
Price vs 200-day SMA	-10.56%
RSI	58.69
RSI Monthly	54.4
RSI Weekly	50.88
Sharpe ratio	0.12x
Sharpe Ratio3y	1.03x
Sortino ratio	0.29
Sortino Ratio3y	2.68
Total Return	-18.73%
Tr YTD	-27.37
Tr1m	28.97%
Tr1w	3.37%
Tr3m	24.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,859,949%
Net Borrowing	-2,333,601.1
Shares Insiders	0.65%
Shares Institutions	103.57%
Shares Qo Q	0.87%
Shares Yo Y	18.73%
Short Ratio	3.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-727.4M
Adjusted OCF	-705,766,941
Average Volume	1,648.7x
Bv Per Share	2.62
CAPEX	$-21.7M
Ch1m	28.97
Ch1w	3.37
Ch1y	-12.92
Ch3m	24.67
Ch3y	488.9
Ch5y	357.6
Ch6m	-13.76
Change	1.87%
Change From Open	-0.37
Close	124.2
Days Gap	2.25
Depreciation Amortization	13,112,333.3
Dollar Volume	72,501.7
Earnings Date	2026-08-06
EBIT	$-612.5M
EBITDA	$-599.2M
EPS	$-3.08
F Score	3
FCF	$-608.7M
FCF EV Yield	-3.02x
Financing CF	93,430,159
Fiscal Year End	December
Founded	1,988
Goodwill	100,865,812.7
Income Tax	$4.7M
Investing CF	-62,398,069
Is Primary Listing	0
Last Earnings Date	2026-08-06
Last Report Date	2026-06-30
Ma150	127.3
Ma150ch	-0.64%
Ma20	126.2
Ma20ch	0.26%
Net CF	-557,405,618
Next Earnings Date	2026-10-29
Open	127
Position In Range	84.07
Ppne	155,476,821
Price Date	2026-09-03
Ptbv Ratio	49.53
Relative Volume	0.22x
Revenue	857,435,500x
SBC By Revenue	13.84x
Share Based Comp	118,692,676
Tax By Revenue	0.55x
Tr6m	-13.76%
Volume	573
Z Score	9.79

LON/0JAV (LON/0JAV)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0JAV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0JAV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0JAV

Frequently asked questions